Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle

Exon skipping is a strategy for the treatment of Duchenne muscular dystrophy, but has variable efficacy. Here, the authors show that dystrophin restoration occurs preferentially in areas of myofiber regeneration, where antisense oligonucleotides are stored in macrophages and delivered to myoblasts a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: James S. Novak, Marshall W. Hogarth, Jessica F. Boehler, Marie Nearing, Maria C. Vila, Raul Heredia, Alyson A. Fiorillo, Aiping Zhang, Yetrib Hathout, Eric P. Hoffman, Jyoti K. Jaiswal, Kanneboyina Nagaraju, Sebahattin Cirak, Terence A. Partridge
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/2bba740be75c451786064cc88308d9ee
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2bba740be75c451786064cc88308d9ee
record_format dspace
spelling oai:doaj.org-article:2bba740be75c451786064cc88308d9ee2021-12-02T14:29:49ZMyoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle10.1038/s41467-017-00924-72041-1723https://doaj.org/article/2bba740be75c451786064cc88308d9ee2017-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-00924-7https://doaj.org/toc/2041-1723Exon skipping is a strategy for the treatment of Duchenne muscular dystrophy, but has variable efficacy. Here, the authors show that dystrophin restoration occurs preferentially in areas of myofiber regeneration, where antisense oligonucleotides are stored in macrophages and delivered to myoblasts and newly formed myotubesJames S. NovakMarshall W. HogarthJessica F. BoehlerMarie NearingMaria C. VilaRaul HerediaAlyson A. FiorilloAiping ZhangYetrib HathoutEric P. HoffmanJyoti K. JaiswalKanneboyina NagarajuSebahattin CirakTerence A. PartridgeNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
James S. Novak
Marshall W. Hogarth
Jessica F. Boehler
Marie Nearing
Maria C. Vila
Raul Heredia
Alyson A. Fiorillo
Aiping Zhang
Yetrib Hathout
Eric P. Hoffman
Jyoti K. Jaiswal
Kanneboyina Nagaraju
Sebahattin Cirak
Terence A. Partridge
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
description Exon skipping is a strategy for the treatment of Duchenne muscular dystrophy, but has variable efficacy. Here, the authors show that dystrophin restoration occurs preferentially in areas of myofiber regeneration, where antisense oligonucleotides are stored in macrophages and delivered to myoblasts and newly formed myotubes
format article
author James S. Novak
Marshall W. Hogarth
Jessica F. Boehler
Marie Nearing
Maria C. Vila
Raul Heredia
Alyson A. Fiorillo
Aiping Zhang
Yetrib Hathout
Eric P. Hoffman
Jyoti K. Jaiswal
Kanneboyina Nagaraju
Sebahattin Cirak
Terence A. Partridge
author_facet James S. Novak
Marshall W. Hogarth
Jessica F. Boehler
Marie Nearing
Maria C. Vila
Raul Heredia
Alyson A. Fiorillo
Aiping Zhang
Yetrib Hathout
Eric P. Hoffman
Jyoti K. Jaiswal
Kanneboyina Nagaraju
Sebahattin Cirak
Terence A. Partridge
author_sort James S. Novak
title Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
title_short Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
title_full Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
title_fullStr Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
title_full_unstemmed Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
title_sort myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/2bba740be75c451786064cc88308d9ee
work_keys_str_mv AT jamessnovak myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
AT marshallwhogarth myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
AT jessicafboehler myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
AT marienearing myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
AT mariacvila myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
AT raulheredia myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
AT alysonafiorillo myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
AT aipingzhang myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
AT yetribhathout myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
AT ericphoffman myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
AT jyotikjaiswal myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
AT kanneboyinanagaraju myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
AT sebahattincirak myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
AT terenceapartridge myoblastsandmacrophagesarerequiredfortherapeuticmorpholinoantisenseoligonucleotidedeliverytodystrophicmuscle
_version_ 1718391181763674112